Sale!

ATXN8OS Gene Spinocerebellar Ataxia Type 8 Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ATXN8OS Gene Spinocerebellar Ataxia Type 8 (SCA8) Autosomal Dominant Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE. This test is designed to identify mutations in the ATXN8OS gene, which are associated with the development of Spinocerebellar Ataxia Type 8, a progressive neurodegenerative disorder. SCA8 is characterized by a wide range of symptoms, including coordination and balance difficulties, speech and swallowing problems, and eye movement abnormalities. The condition is inherited in an autosomal dominant manner, meaning that a mutation in just one copy of the gene is sufficient to cause the disorder.

The test is critical for individuals with a family history of SCA8 or those exhibiting symptoms consistent with the condition, as it can provide a definitive diagnosis. Early identification of the disease can help in managing symptoms and planning for future care needs. The testing process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the ATXN8OS gene.

DNA Labs UAE offers this genetic test at a cost of 4400 AED. The facility is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable results. Opting for this test at DNA Labs UAE not only aids in the diagnosis of SCA8 but also contributes to a better understanding of the genetic factors influencing the disorder, potentially guiding treatment options and family planning decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ATXN8OS Gene Spinocerebellar ataxia type 8 autosomal dominant Genetic Test

Welcome to DNA Labs UAE, where we offer the ATXN8OS Gene Spinocerebellar ataxia type 8 autosomal dominant Genetic Test. This test is designed to diagnose and analyze the ATXN8OS gene associated with Spinocerebellar ataxia type 8 (SCA8), an autosomal dominant genetic disorder.

Test Components and Price

The price for the ATXN8OS Gene Spinocerebellar ataxia type 8 autosomal dominant Genetic Test is 4400.0 AED. The test requires a blood or extracted DNA sample, or one drop of blood on an FTA Card.

Report Delivery

The report for the ATXN8OS Gene Spinocerebellar ataxia type 8 autosomal dominant Genetic Test will be delivered within 3 to 4 weeks.

Method

The ATXN8OS Gene Spinocerebellar ataxia type 8 autosomal dominant Genetic Test utilizes NGS (Next-Generation Sequencing) technology to analyze multiple genes simultaneously and identify genetic variations or mutations associated with neurological disorders.

Test Type

The ATXN8OS Gene Spinocerebellar ataxia type 8 autosomal dominant Genetic Test falls under the category of Neurological Disorders.

Doctor and Test Department

This test is performed by a Neurologist in our Genetics department.

Pre Test Information

Before undergoing the ATXN8OS Gene Spinocerebellar ataxia type 8 autosomal dominant Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by ATXN8OS Gene Spinocerebellar ataxia type 8 autosomal dominant.

Test Details

The ATXN8OS (Ataxin 8 opposite strand) gene is associated with Spinocerebellar ataxia type 8 (SCA8), which is characterized by progressive cerebellar ataxia. This disorder leads to problems with coordination and balance.

The NGS genetic testing technique is used to analyze the ATXN8OS gene and identify any mutations or expansions responsible for the development of SCA8. This test involves extracting DNA from a blood or saliva sample and sequencing the ATXN8OS gene to detect variations or mutations.

The ATXN8OS Gene Spinocerebellar ataxia type 8 autosomal dominant Genetic Test is essential for confirming a diagnosis of SCA8 and can also be utilized for genetic counseling and family planning purposes.

Please note that it is crucial to consult with a healthcare professional or genetic counselor for proper interpretation of the test results and to receive appropriate counseling and support.

Test Name ATXN8OS Gene Spinocerebellar ataxia type 8 autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ATXN8OS Gene Spinocerebellar ataxia type 8, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATXN8OS Gene Spinocerebellar ataxia type 8, autosomal dominant
Test Details

ATXN8OS (Ataxin 8 opposite strand) gene is associated with Spinocerebellar ataxia type 8 (SCA8), an autosomal dominant genetic disorder. SCA8 is characterized by progressive cerebellar ataxia, which leads to problems with coordination and balance.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify genetic variations or mutations that may be associated with a particular disorder. In the case of SCA8, NGS genetic testing can be used to identify mutations or expansions in the ATXN8OS gene that are responsible for the development of the disorder.

The NGS genetic test for SCA8 typically involves extracting DNA from a blood or saliva sample and sequencing the ATXN8OS gene to identify any variations or mutations. This test can help in confirming a diagnosis of SCA8 and can also be used for genetic counseling and family planning purposes.

It’s important to note that genetic testing should be done under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and support.